3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
11
Lung Neoplasms
8
Neoplasms
7
Prostatic Neoplasms
6
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Melanoma
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasm Metastasis
4
Hematologic Neoplasms
4
Esophageal Neoplasms
4
Multiple Myeloma
3
Carcinoma, Renal Cell
3
COVID-19
3
Barrett Esophagus
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Papillomavirus Infections
2
Ovarian Neoplasms
2
Leukemia, Myeloid, Acute
2
Genetic Predisposition to Disease
2
Endometrial Neoplasms
2
Diabetes Mellitus
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Adenocarcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Interventions
Specimen Handling
1
Mastectomy, Subcutaneous
1
Mastectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Li-Fraumeni Syndrome
×
Specimen Handling
×
Clear all
NCT04541654
2026-03-27
LiFT_UP
Dana-Farber Cancer Institute
Recruiting
1,500 enrolled